J. Safra Sarasin Holding’s Gilead Sciences GILD Stock Holding History

J. Safra Sarasin Holding’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$101M	Sell	721,261 -98,142	-12%	-$13.7M	1.71%	13
2025 Q4	$101M	Sell	819,403 -78,390	-9%	-$9.53M	1.64%	11
2025 Q3	$99.7M	Buy	897,793 +167,263	+23%	+$19M	1.61%	11
2025 Q2	$81M	Sell	730,530 -48,525	-6%	-$5.16M	1.4%	17
2025 Q1	$87.3M	Sell	779,055 -23,142	-3%	-$2.39M	1.58%	12
2024 Q4	$74.1M	Sell	802,197 -20,537	-2%	-$1.85M	1.25%	18
2024 Q3	$69M	Sell	822,734 -15,409	-2%	-$1.18M	1.2%	24
2024 Q2	$57.5M	Buy	+838,143	New	+$55.9M	1.05%	29

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

J. Safra Sarasin Holding's GILD Position: Q1 2026 in Review

J. Safra Sarasin Holding reduced its Gilead Sciences (GILD) stake by 12% in Q1 2026, selling an estimated $13.7M and leaving 721,261 shares worth $101M. The position accounts for 1.71% of the portfolio, ranked #13.

J. Safra Sarasin Holding first reported a position in GILD in Q2 2024 and has held it in 8 quarters since. The position peaked at $101M in Q4 2025. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

J. Safra Sarasin Holding held 721,261 shares of Gilead Sciences worth $101M as of Q1 2026.
J. Safra Sarasin Holding sold 98,142 Gilead Sciences shares in Q1 2026, an estimated $13.7M.
Gilead Sciences made up 1.71% of J. Safra Sarasin Holding's portfolio in Q1 2026, its #13 holding.
J. Safra Sarasin Holding first reported a position in Gilead Sciences in Q2 2024 and has held it in 8 quarters since.
J. Safra Sarasin Holding's Gilead Sciences position peaked at $101M in Q4 2025.
2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on J. Safra Sarasin Holding's 13F filing for Q1 2026, filed 4 May 2026.